134 related articles for article (PubMed ID: 58520)
41. Acquired cell-mediated immunodepression in acute Chagas' disease.
Teixeira AR; Teixeira G; Macêdo V; Prata A
J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
[TBL] [Abstract][Full Text] [Related]
42. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
43. Cell-mediated immune response in cattle to bovine respiratory syncytial virus.
Field EW; Smith MH
Am J Vet Res; 1984 Aug; 45(8):1641-3. PubMed ID: 6383149
[TBL] [Abstract][Full Text] [Related]
44. [Significance of the leukocyte migration inhibition test (MIT) in the study of cellular immunity].
Steruská M; Chabronová J; Cupaníková D; Seichertová E
Vnitr Lek; 1977 Sep; 23(9):911-6. PubMed ID: 335648
[No Abstract] [Full Text] [Related]
45. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.
Geczy CL; Meyer PA
J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485
[TBL] [Abstract][Full Text] [Related]
46. Correlations between DNCB skin hypersensitivity and leukocyte migration inhibition by DNCB-coated human erythrocytes.
Walewski J; Nowakowska A
Arch Immunol Ther Exp (Warsz); 1981; 29(1):29-33. PubMed ID: 7283677
[TBL] [Abstract][Full Text] [Related]
47. Alterations of two parameters of cellular immunity in the aged men.
Rédei A; Biró J; Kun Z
Aktuelle Gerontol; 1979 Oct; 9(10):477-9. PubMed ID: 43677
[TBL] [Abstract][Full Text] [Related]
48. Immune sensitization against epidermal antigens in polymorphous light eruption.
González-Amaro R; Baranda L; Salazar-Gonzalez JF; Abud-Mendoza C; Moncada B
J Am Acad Dermatol; 1991 Jan; 24(1):70-3. PubMed ID: 1999534
[TBL] [Abstract][Full Text] [Related]
49. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
McCoy JL; Dean JH; Herberman RB
J Immunol Methods; 1977; 15(4):355-71. PubMed ID: 874326
[TBL] [Abstract][Full Text] [Related]
50. A comparison of the inhibition of leucocyte migration and monocyte spreading as in vitro assays for tuberculin hypersensitivity in man.
Silobrcić V; Sabioncello A; Mazuran R; Dekaris D; Kadrnka-Lovrencić M
Clin Exp Immunol; 1975 May; 20(2):239-47. PubMed ID: 813926
[TBL] [Abstract][Full Text] [Related]
51. Human leukocyte migration inhibition as an indicator of cellular hypersensitivity to soluble antigens.
Rauch HC; King K
Int Arch Allergy Appl Immunol; 1973; 44(6):862-74. PubMed ID: 4199134
[No Abstract] [Full Text] [Related]
52. Leukocyte migration inhibition assay in hepatoma patients and normal individuals: correlations with skin test.
Lee CS; Jan YY; Lin TY
Taiwan Yi Xue Hui Za Zhi; 1978 Sep; 77(9):661-5. PubMed ID: 214516
[No Abstract] [Full Text] [Related]
53. [Leukocyte migration inhibition reaction in response to ginigval antigen in parodontosis].
Mashchenko IS
Stomatologiia (Mosk); 1977; 56(5):34-6. PubMed ID: 302995
[No Abstract] [Full Text] [Related]
54. [Leukocyte migration inhibition phenomenon in tuberculosis of the kidneys and urogenital organs].
Kitaev MI; Ybykeev OY; Salimov SE
Zdravookhr Kirg; 1976; (4):9-11. PubMed ID: 8933
[No Abstract] [Full Text] [Related]
55. [Cellular immunity responses in studies of the specificity of leukocyte hepatitis virus].
Barinskiĭ IF; Shubladze AK; Semendiaeva ME; Blinkov IL; Severov MV
Vopr Virusol; 1976; (5):550-5. PubMed ID: 64028
[TBL] [Abstract][Full Text] [Related]
56. A study of different parameters of cell-mediated immunity in patients with active and chronic tuberculosis.
Maroto MC; Galán MI; Carrión P; Leyva A; Bernal MC; Piedrola G
J Investig Allergol Clin Immunol; 1991 Jun; 1(3):204-8. PubMed ID: 1669579
[TBL] [Abstract][Full Text] [Related]
57. [Immunologic capacity of tumour patients. I. Leukocyte migration inhibition with ppD in patients at different tumour stages].
Makidono R; Murakami J; Jingu K; Kitagawa S; Matsuura K; Makidono A
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Feb; 45(2):403-6. PubMed ID: 4011416
[No Abstract] [Full Text] [Related]
58. Leukocyte migration inhibition by dental plaque antigens as indicated by the capillary tube and the agarose plate technique.
Budtz-Jörgensen E; Kelstrup J; Budtz-Jörgensen A
J Periodontal Res; 1976 Apr; 11(2):86-95. PubMed ID: 132521
[No Abstract] [Full Text] [Related]
59. The effect of skin testing on cellular immunity as measured in vitro by leukocyte migration inhibition.
Ramsey EW; Brandes LJ; Goldenberg GJ
Cell Immunol; 1977 Apr; 30(1):156-61. PubMed ID: 862033
[No Abstract] [Full Text] [Related]
60. Circadian rhythms in cell migration in vitro, and its effect on antigen-induced migration inhibition.
Richens E; Brown KA; Collins AJ; Bacon PA
Clin Exp Immunol; 1975 Feb; 19(2):343-6. PubMed ID: 1212804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
